While NAD supplements exist, their effectiveness is questionable due to poor bioavailability when taken orally
Safety Note: Avoid Compounded GLP-1 Products The FDA has raised concerns about unapproved GLP-1 drugs sold online and compounded products using semaglutide salt forms that are not the same active ingredient as approved medications
doi: 10.1152/ajprenal.00426.2020 218 EzquerFGiraud-BilloudMCarpioDCabezasFCongetPEzquerM
Participants were randomized to tirzepatide 5mg, 10mg, or 15mg, or placebo, administered weekly for 72 weeks
As a comparison point, the American Diabetes Association Standards of Care (2024) recommend GLP-1 receptor agonists for patients with type 2 diabetes and established cardiovascular disease or high cardiovascular risk, regardless of HbA1c level
doi: 10.1016/j.parkreldis.2009.05.005 95 FanZAmanYAhmedIChetelatGLandeauBRay ChaudhuriKet al